7-150947630-T-C
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_000238.4(KCNH2):āc.2941A>Gā(p.Ser981Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000289 in 1,612,644 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. S981S) has been classified as Likely benign.
Frequency
Consequence
NM_000238.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNH2 | NM_000238.4 | c.2941A>G | p.Ser981Gly | missense_variant | Exon 12 of 15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNH2 | ENST00000262186.10 | c.2941A>G | p.Ser981Gly | missense_variant | Exon 12 of 15 | 1 | NM_000238.4 | ENSP00000262186.5 | ||
KCNH2 | ENST00000330883.9 | c.1921A>G | p.Ser641Gly | missense_variant | Exon 8 of 11 | 1 | ENSP00000328531.4 | |||
KCNH2 | ENST00000684241.1 | n.3774A>G | non_coding_transcript_exon_variant | Exon 10 of 13 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152182Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000269 AC: 66AN: 244912Hom.: 0 AF XY: 0.000270 AC XY: 36AN XY: 133284
GnomAD4 exome AF: 0.000294 AC: 430AN: 1460346Hom.: 0 Cov.: 36 AF XY: 0.000284 AC XY: 206AN XY: 726430
GnomAD4 genome AF: 0.000236 AC: 36AN: 152298Hom.: 0 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74450
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:3Other:1
- -
- -
Observed in two individuals diagnosed with hypertrophic cardiomyopathy (Lopes et al., 2015) and one individual with a history of sudden unexplained death (Sanchez et al., 2016) in the published literature.; Identified in a cohort of ostensibly healthy control individuals (Kappa et al., 2009), a cohort of individuals who underwent exome sequencing who were not selected for cardiomyopathy, arrhythmia, or a family history of sudden cardiac death (Ng et al., 2013), and a cohort of individuals recruited for non-antiarrhythmic drug exposure phenotypes who underwent pharmacogenomic testing (Van Driest et al., 2016); Reported with conflicting interpretations of pathogenicity by other clinical laboratories in ClinVar (ClinVar Variant ID# 67454; Landrum et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 27930701, 22949429, 19841300, 22581653, 23861362, 26746457, 25351510) -
This variant has been reported in the following publications (PMID:19841300). -
- -
not specified Uncertain:1
The KCNH2 c.2941A>G; p.Ser981Gly variant (rs76649554; ClinVar Variation ID: 67454) has been previously reported in two individuals included in a cohort of hypertrophic cardiomyopathy (HCM) patients (Lopes 2015). However, this variant has also been identified in several control cohorts (Kapa 2009, Giudicessi 2012, Ng 2013, Van Driest 2016), and is also found in the general population with an overall allele frequency of 0.03% (75/276,264 alleles) in the Genome Aggregation Database. The serine at codon 981 is moderately conserved (Alamut software v2.11) and computational analyses (SIFT: damaging, PolyPhen-2: benign) predict conflicting effects of this variant on protein structure/function. Based on the available information, the clinical significance of this variant is uncertain. References: Giudicessi JR et al. Phylogenetic and physicochemical analyses enhance the classification of rare nonsynonymous single nucleotide variants in type 1 and 2 long-QT syndrome. Circ Cardiovasc Genet. 2012 Oct 1;5(5):519-28. Kapa et al. Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants. Circulation. 2009 Nov 3;120(18):1752-60. Lopes LR et al. Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy. Heart. 2015 Feb;101(4):294-301. Ng D et al. Interpreting secondary cardiac disease variants in an exome cohort. Circ Cardiovasc Genet. 2013 Aug;6(4):337-46. Van Driest SL et al. Association of Arrhythmia-Related Genetic Variants With Phenotypes Documented in Electronic Medical Records. JAMA. 2016 Jan 5;315(1):47-57. -
Long QT syndrome Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Cardiac arrhythmia Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at